Camlin Fine Sciences Stock Screener | Share Price & Fundamental Analysis
CAMLINFINE
Specialty Chemicals
Screen Camlin Fine Sciences share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹142.99
▼
-1.42 (-0.98%)
Share Price BSE
₹143.15
▼
-1.15 (-0.80%)
Market Cap
₹2,878.42 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.10
EPS (TTM)
₹-8.03
Dividend Yield
-
Debt to Equity
0.79
52W High
₹231.00
52W Low
₹142.99
Operating Margin
7.00%
Profit Margin
-
Revenue (TTM)
₹449.00
EBITDA
₹43.00
Net Income
-
Total Assets
₹2,024.00
Total Equity
₹875.00
Camlin Fine Sciences Share Price History - Stock Screener Chart
Screen CAMLINFINE historical share price movements with interactive charts. Analyze price trends and patterns.
Camlin Fine Sciences Company Profile - Fundamental Screener
Screen Camlin Fine Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CAMLINFINE shares.
Sector
Chemicals
Industry
Specialty Chemicals
Sub-Sector
Specialty Chemicals
Segment
E
ISIN
INE052I01032
Camlin Fine Sciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen CAMLINFINE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 2,024 | 1,952 | 2,060 | 1,800 | 1,482 | 1,234 | 1,087 | 1,017 | 673 | 483 |
| Current Assets | 1,183 | 1,001 | 1,088 | 894 | 795 | 675 | 673 | 666 | 419 | 300 |
| Fixed Assets | 704 | 816 | 858 | 601 | 584 | 306 | 272 | 278 | 201 | 140 |
| Liabilities | ||||||||||
| Total Liabilities | 2,024 | 1,952 | 2,060 | 1,800 | 1,482 | 1,234 | 1,087 | 1,017 | 673 | 483 |
| Current Liabilities | 303 | 363 | 443 | 440 | 291 | 226 | 196 | 112 | 57 | 27 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 875 | 857 | 824 | 765 | 713 | 460 | 430 | 433 | 230 | 176 |
| Share Capital | 19 | 17 | 16 | 16 | 13 | 12 | 12 | 12 | 10 | 10 |
| Reserves & Surplus | 880 | 845 | 800 | 729 | 582 | 388 | 355 | 359 | 202 | 167 |
Screen CAMLINFINE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 449 | 433 | 464 | 382 | 383 | 429 | 432 | 429 | 426 | 408 | 388 | 411 | 385 | 486 | 398 |
| Expenses | 406 | 411 | 436 | 446 | 368 | 529 | 384 | 393 | 381 | 381 | 363 | 365 | 337 | 428 | 338 |
| EBITDA | 43 | 22 | 29 | -64 | 14 | -100 | 48 | 36 | 45 | 27 | 25 | 46 | 48 | 58 | 60 |
| Operating Profit % | 7.00% | 3.00% | 5.00% | -19.00% | 3.00% | -27.00% | 11.00% | 8.00% | 9.00% | 6.00% | 6.00% | 6.00% | 12.00% | 11.00% | 13.00% |
| Depreciation | 18 | 17 | 19 | 13 | 15 | 17 | 15 | 18 | 19 | 19 | 21 | 16 | 14 | 14 | 16 |
| Interest | 16 | 16 | 19 | 16 | 23 | 26 | 34 | 10 | 10 | 20 | 14 | 10 | 19 | 19 | 12 |
| Profit Before Tax | 8 | -11 | -9 | -94 | -24 | -142 | 0 | 8 | 16 | -12 | -10 | 20 | 15 | 26 | 32 |
| Tax | 8 | 0 | 6 | -12 | 11 | -26 | 7 | 5 | 4 | 9 | 5 | 7 | 11 | 16 | 9 |
| Net Profit | 0 | -11 | -15 | -82 | -35 | -116 | -8 | 4 | 12 | -21 | -14 | 13 | 4 | 10 | 23 |
| EPS | -0.04 | -0.53 | -0.76 | -4.64 | -2.00 | -5.88 | -0.24 | 0.59 | 0.96 | -1.17 | -0.71 | 1.16 | 0.37 | 0.83 | 1.53 |
Camlin Fine Sciences Cash Flow Screener - Liquidity Fundamentals
Screen CAMLINFINE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 27 | 139 | 51 | 145 | 117 | 86 | -9 | -15 | -9 | 72 |
| Investing Activities | -75 | -67 | -125 | -249 | -133 | -90 | -2 | -149 | -70 | -66 |
| Financing Activities | 72 | -86 | 60 | 136 | 39 | 3 | 26 | 182 | 91 | -7 |
| Net Cash Flow | 24 | -14 | -14 | 32 | 23 | -1 | 15 | 18 | 13 | -1 |
Screen CAMLINFINE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Jan | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Nov | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 49.10% | 49.10% | 49.10% | 49.08% | 48.03% | 49.08% | 48.03% | 48.02% |
| FII Holding | 0.82% | 1.47% | 2.88% | 2.12% | 2.15% | 2.12% | 1.69% | 1.01% |
| DII Holding | 4.09% | 3.83% | 4.14% | 5.48% | 7.78% | 5.48% | 4.54% | 4.89% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 33.14% | 32.85% | 30.98% | 29.20% | 26.89% | 29.20% | 32.75% | 33.89% |
| Other Holding | 12.85% | 12.75% | 12.89% | 14.13% | 15.15% | 14.13% | 12.99% | 12.19% |
| Shareholder Count | 61,893 | 60,554 | 58,111 | 59,538 | 57,661 | 52,845 | 62,098 | 58,165 |
Camlin Fine Sciences Dividend Screener - Share Yield Analysis
Screen CAMLINFINE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Camlin Fine Sciences Index Membership - Market Screener Classification
Screen CAMLINFINE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Camlin Fine Sciences Market Events Screener - Corporate Actions
Screen CAMLINFINE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.05% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -8.63% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | 26.19% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 9.49% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 5.94% |
| 2025-01-08 | 2025-01-08 | Rights | 5:41 | -2.16% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 16.05% |
| 2024-07-31 | 2024-07-31 | Annual General Meeting | NA | 19.06% |
Camlin Fine Sciences Competitors Screener - Peer Comparison
Screen CAMLINFINE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 150,438 | 66.54 | 13,388 | 6.91% | 2,096 | 54.30 |
| SRF | 90,691 | 56.05 | 14,826 | 12.13% | 1,251 | 57.73 |
| Gujarat Fluorochemicals | 40,073 | 59.38 | 4,853 | 10.61% | 546 | 58.68 |
| Navin Fluorine International | 30,237 | 68.42 | 2,393 | 12.83% | 289 | 51.09 |
| Himadri Speciality Chemical | 24,922 | 37.54 | 4,664 | 10.33% | 555 | 64.92 |
| Deepak Nitrite | 23,338 | 43.67 | 8,366 | 7.84% | 697 | 59.17 |
| Atul | 17,987 | 32.27 | 5,692 | 18.99% | 499 | 56.69 |
| BASF | 17,032 | 45.12 | 15,339 | 10.81% | 479 | 42.95 |
| Vinati Organics | 16,599 | 37.96 | 2,293 | 18.24% | 405 | 52.38 |
| Anupam Rasayan | 15,088 | 67.61 | 1,449 | -3.77% | 160 | 64.81 |
Camlin Fine Sciences Company Announcements - News Screener
Screen CAMLINFINE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-05 | Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Asst./Dy. Commissioner Of (CGST & Central Excise) Division-IV | View |
| 2025-12-29 | Press Release Issued By The Company | View |
| 2025-12-28 | Closure of Trading Window | View |
| 2025-12-15 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-12-15 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-30 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2025-11-30 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-30 | Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors Of The Company | View |
| 2025-11-28 | Press Release Issued By The Company | View |
| 2025-11-26 | Press Release Issued By The Company. | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-13 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-10 | Grant Of Esops Under CFSL ESOP - 2021 | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-10 | Un-Audited Financial Results As On 30.09.2025 | View |